Related Experiment Video
Updated: Jun 4, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer
G Mudduluru1, P Ceppi, R Kumarswamy
1Department of Experimental Surgery and Molecular Oncology of Solid Tumors, University of Heidelberg, and German Cancer Research Center (DKFZ), Germany.
Abstract:
Axl is a receptor that induces proliferation, migration and invasion in cancer. In this study, we show that specific microRNAs (miRNAs) target the 3'-UTR of Axl. Luciferase-reporter assays with wild-type and deleted miR-34 and miR-199a/b seed sequences of Axl 3'-UTR confirmed the specificity of targeting. An inverse correlation between Axl protein and miR-34a expression in a panel of non-small cell lung cancer (NSCLC), colorectal cancer (CRC) and breast cancer (BRC) cell lines was observed, while miR-199a/b expression was completely suppressed. Pre-miR transfection inhibited in vitro migration and invasion and, in vivo, reduced the number of distant lung- or liver-metastases in a chorion-allantoic-membrane (CAM) assay. Moreover, methylation-specific PCR on bisulfite-converted DNA obtained from the cell lines showed that the miR-34a promoter methylation status was inversely correlated with its expression, and that miR-199a/b promoter regions were methylated in all cells tested. In a panel of NSCLC tissues (n=44), miR-34a and miR-199a/b were found to be downregulated and significantly co-expressed. A lower expression of all three miRs was significantly associated with squamous histotypes, and, in a preliminary series, NSCLC patients with miR-34a upregulation showed a positive association towards a longer survival. These results indicate that Axl receptor expression can be regulated by miR-34a and miR-199a/b, which are suppressed by promoter methylation in solid cancer cells.
Insights
Specific microRNAs (miRNAs), miR-34a and miR-199a/b, regulate the Axl receptor, a key driver of cancer proliferation and metastasis. Their suppression via promoter methylation is linked to cancer progression and reduced survival in non-small cell lung cancer.
Area of Science:
- Molecular Biology
- Oncology
- Gene Regulation
Background:
- Axl receptor tyrosine kinase promotes cancer cell proliferation, migration, and invasion.
- MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression post-transcriptionally.
- Dysregulation of miRNAs and Axl is implicated in various cancers.
Purpose of the Study:
- To investigate the role of specific miRNAs, miR-34a and miR-199a/b, in regulating Axl expression.
- To determine the correlation between Axl protein levels and these miRNAs in cancer cell lines and tissues.
- To explore the mechanisms of miRNA suppression, including promoter methylation, and their impact on cancer progression.
Main Methods:
- Luciferase-reporter assays to confirm miRNA targeting of Axl 3'-UTR.
- Analysis of Axl protein and miRNA expression in cancer cell lines (NSCLC, CRC, BRC).
- In vitro and in vivo functional assays (pre-miR transfection, CAM assay) to assess the effect of miRNAs on migration, invasion, and metastasis.
- Methylation-specific PCR to evaluate promoter methylation status of miR-34a and miR-199a/b.
- Expression analysis of miR-34a and miR-199a/b in non-small cell lung cancer (NSCLC) tissues.
Main Results:
- miR-34a and miR-199a/b were confirmed to directly target the 3'-UTR of Axl.
- Inverse correlation observed between Axl protein and miR-34a expression; miR-199a/b expression was suppressed.
- Transfection with pre-miRs inhibited cancer cell migration, invasion, and reduced metastasis in vivo.
- Promoter methylation was identified as a mechanism for miR-34a and miR-199a/b suppression.
- Downregulation and co-expression of miR-34a and miR-199a/b were found in NSCLC tissues, associated with squamous histotypes.
- Preliminary data suggested a positive association between miR-34a upregulation and longer survival in NSCLC patients.
Conclusions:
- miR-34a and miR-199a/b act as tumor suppressors by regulating Axl expression.
- Promoter methylation is a key mechanism for the silencing of these tumor-suppressive miRNAs in solid cancers.
- Downregulation of miR-34a and miR-199a/b contributes to cancer progression and metastasis.
- These miRNAs represent potential therapeutic targets for cancer treatment.
Related Concept Videos
Abnormal Proliferation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MicroRNAs
MicroRNAs
Mitogens and the Cell Cycle
